Specifically, miR-193b-3p inhibits dimethylarginine dimethylaminohydrolase 1 (DDAH1), a regulator of angiogenesis and vasculogenic mimicry in aggressive breast cancer cells. Here, DDAH1 is linked to breast cancer.